[ESPR] QoQ Quarter Result on 30-Jun-2001 [#Q2]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
29-Jun-2001
Financial Year
2001
Quarter
30-Jun-2001 [#Q2]
Profit Trend
QoQ- -5.75%
YoY- 2.90%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 31/12/00 30/09/00 CAGR
Revenue 0 0 0 1 1 1 1 -
PBT -7,303 -6,344 -6,281 -6,325 -5,981 -6,803 -11,693 -26.95%
Tax 314 -112 736 -454 -976 1,233 3,556 -80.19%
NP -7,303 -6,344 -6,281 -6,325 -5,981 -5,565 -10,804 -22.99%
Tax Rate - - - - - - - -
Total Cost 7,303 6,344 6,281 6,326 5,982 5,566 10,805 -23.00%
Ratio Analysis
31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 31/12/00 30/09/00 CAGR
NP Margin 0.00 0.00 0.00 -632,500.00 -598,100.00 -556,500.00 -1,080,400.00 -
Per Share
31/03/02 31/12/01 30/09/01 30/06/01 31/03/01 31/12/00 30/09/00 CAGR
EPS -1.75 -1.57 -1.56 -1.70 -1.61 -2.65 -5.14 -51.27%
EPS Diluted -1.75 -1.57 -1.56 -1.70 -1.61 -2.65 -5.14 -51.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.